Morphic Holding
MORF · NASDAQ
Price unavailable right now.
No price history for this range.
Who owns MORF
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 12.0% of MORF’s shares.
- Springer Timothy A6.0%
- Polaris Venture Partners4.0%
- Tipirneni (Praveen P)1.2%
- Nomura Asset Management Co., Ltd.0.3%
- Next 6 largest institutions0.5%
- All other shareholders88.0%
| Holder | Shares | % of shares |
|---|---|---|
| Springer Timothy A | 3.03M | 6.03% |
| Polaris Venture Partners | 1.99M | 3.96% |
| Tipirneni (Praveen P) | 614.47K | 1.22% |
| Nomura Asset Management Co., Ltd. | 146.30K | 0.29% |
| Medical Strategy GmbH | 128.96K | 0.26% |
| Wellington Management Singapore Pte. Ltd. | 33.08K | 0.07% |
| Wellington Management Japan Pte Ltd | 31.75K | 0.06% |
| DeVaul (William David) | 22.17K | 0.04% |
| T. Rowe Price Japan, Inc. | 15.50K | 0.03% |
| Neuberger Berman Investment Advisors LLC | 13.81K | 0.03% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| SSgA Russell Small/Mid Cap Index SL | 155.47K | 0.31% |
| APO Medical Opportunities | 128.96K | 0.26% |
| Nomura World Genome Technology Open B | 91.91K | 0.18% |
| TD Health Sciences Fund | 56.05K | 0.11% |
| Nomura World Genome Technology Open A Course | 54.39K | 0.11% |
Short interest
Settled Aug 15, 2024
- Shares short
- 1.26M
- Days to cover
- 1.00
- % of shares outstanding
- 2.51%
- Average daily volume
- 1.95M
- Change since last report
- −33.5%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.